GlassScriptPhysician profile
George Nunez
NPI 1346229150
$3,103.83
in general payments reported to CMS, 2019-2025
23 companies · $414 in 2025
The $414 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $801 · 2020: $624 · 2021: $566 · 2022: $402 · 2023: $86.69 · 2024: $210 · 2025: $414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $710.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $926.94 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $599.04 | 2019-2025 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $264.72 | 2019-2025 | Entyvio |
| Ferring Pharmaceuticals INC. | $183.37 | 2019-2022 | |
| Merz North America, INC. | $150.15 | 2019 | |
| Celgene Corporation | $131.23 | 2021-2024 | Zeposia |
| Madrigal Pharmaceuticals | $117.89 | 2025 | Rezdiffra |
| Gilead Sciences, INC. | $110.89 | 2020-2025 | |
| Romark Laboratories, Lc | $96.17 | 2019-2020 | |
| Pfizer INC. | $88.92 | 2025 | |
| Redhill Biopharma INC. | $82.08 | 2020-2021 | |
| Argenx US, INC. | $59.60 | 2025 | Vyvgart Hytrulo |
| Conmed Corporation | $42.84 | 2020-2021 | |
| Janssen Biotech, INC. | $41.93 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $30.45 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $28.82 | 2024 | Barrx |
| Ucb, INC. | $27.56 | 2023 | |
| Braintree Laboratories, INC. | $24.31 | 2019 | |
| Phathom Pharmaceuticals, INC. | $23.34 | 2025 | Voquezna |
| Ironwood Pharmaceuticals, INC | $19.77 | 2019 | |
| Nestle Healthcare Nutrition INC. | $19.47 | 2020 | |
| Intercept Pharmaceuticals, INC. | $17.39 | 2019 | |
| Enterra Medical, INC. | $16.95 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Nunez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.